Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.

Cancer Med · 2026 · PMC13239794 · PMID 42163828

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

did not reach statistical significancep < 0.001actually significant

In the multivariate model for OS, RCB‐III remained an independent adverse prognostic factor (HR: 19.078, 95% CI: 4.127–88.183, p = 0.002), whereas RCB‐I and RCB‐II did not reach statistical significance. For disease‐free survival, univariate analysis showed that pCR was strongly associated with improved DFS (HR: 0.073, 95% CI: 0.028–0.187, p < 0.001).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.